Abstract:Tumor-associated macrophages (TAMs) are predominantly present in the tumor microenvironment (TME) and play a crucial role in shaping the efficacy of tumor immunotherapy. These TAMs primarily exhibit a tumor-promoting M2-like phenotype, which is associated with the suppression of immune responses and facilitation of tumor progression. Interestingly, recent research has highlighted the potential of repolarizing TAMs from an M2 to a pro-inflammatory M1 status-a shift that has shown promise in impeding tumor growth and enhancing immune responsiveness. This concept is particularly intriguing as it offers a new dimension to cancer therapy by targeting the tumor microenvironment, which is a significant departure from traditional approaches that focus solely on tumor cells. However, the clinical application of TAM-modulating agents is often challenged by issues such as insufficient tumor accumulation and off-target effects, limiting their effectiveness and safety. In this regard, nanomaterials have emerged as a novel solution. They serve a dual role: as delivery vehicles that can enhance the accumulation of therapeutic agents in the tumor site and as TAM-modulators. This dual functionality of nanomaterials is a significant advancement as it addresses the key limitations of current TAM-modulating strategies and opens up new avenues for more efficient and targeted therapies. This review provides a comprehensive overview of the latest mechanisms and strategies involving nanomaterials in modulating macrophage polarization within the TME. It delves into the intricate interactions between nanomaterials and macrophages, elucidating how these interactions can be exploited to drive macrophage polarization towards a phenotype that is more conducive to anti-tumor immunity. Additionally, the review explores the burgeoning field of TAM-associated nanomedicines in combination with tumor immunotherapy. This combination approach is particularly promising as it leverages the strengths of both nanomedicine and immunotherapy, potentially leading to synergistic effects in combating cancer.

Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer

Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer

Research advances on signaling pathways regulating the polarization of tumor-associated macrophages in lung cancer microenvironment

Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials

Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy.

Natural compounds modulate the mechanism of action of tumour-associated macrophages against colorectal cancer: a review

Cutting edges and therapeutic opportunities on tumor-associated macrophages in lung cancer

Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy

The role of tumor-associated macrophages in lung cancer: From mechanism to small molecule therapy

Mechanistic studies of tumor-associated macrophage immunotherapy

Decoding the spatiotemporal heterogeneity of tumor-associated macrophages

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy

Natural products targeting macrophages in tumor microenvironment are a source of potential antitumor agents

Polarization of tumor-associated macrophage phenotype via porous hollow iron nanoparticles for tumor immunotherapy in vivo.

Roles of Tumor-Associated Macrophages in Tumor Environment and Strategies for Targeting Therapy

Targeting tumor-associated macrophages for cancer treatment

Macrophage Polarization: Anti-Cancer Strategies to Target Tumor-Associated Macrophage in Breast Cancer

Tumor-associated Macrophages in Lung Carcinoma: from Mechanism to Therapy.

Nanoparticles targeting tumor-associated macrophages: A novel anti-tumor therapy

Nanomaterials in modulating tumor-associated macrophages and enhancing immunotherapy

The Polarization of Tumor-Associated Macrophages as an Effective Therapeutic Strategy: A Comprehensive Analysis